249 related articles for article (PubMed ID: 28927253)
1. Comparative aspects of microRNA expression in canine and human cancers.
Sahabi K; Selvarajah GT; Abdullah R; Cheah YK; Tan GC
J Vet Sci; 2018 Mar; 19(2):162-171. PubMed ID: 28927253
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of circulating serum microRNAs in dogs with lymphoma.
Fujiwara-Igarashi A; Igarashi H; Mizutani N; Goto-Koshino Y; Takahashi M; Ohno K; Tsujimoto H
Vet J; 2015 Aug; 205(2):317-21. PubMed ID: 26002992
[TBL] [Abstract][Full Text] [Related]
3. Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.
Rybicka A; Mucha J; Majchrzak K; Taciak B; Hellmen E; Motyl T; Krol M
J Physiol Pharmacol; 2015 Feb; 66(1):29-37. PubMed ID: 25716962
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression in canine mammary cancer.
Boggs RM; Wright ZM; Stickney MJ; Porter WW; Murphy KE
Mamm Genome; 2008 Aug; 19(7-8):561-9. PubMed ID: 18665421
[TBL] [Abstract][Full Text] [Related]
5. The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.
Albonico F; Mortarino M; Avallone G; Gioia G; Comazzi S; Roccabianca P
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):117-23. PubMed ID: 23871213
[TBL] [Abstract][Full Text] [Related]
6. Micro RNA differential expression profile in canine mammary gland tumor by next generation sequencing.
Chen HW; Lai YC; Rahman MM; Husna AA; Hasan MN; Miura N
Gene; 2022 Apr; 818():146237. PubMed ID: 35077831
[TBL] [Abstract][Full Text] [Related]
7. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.
Chakrabortty A; Patton DJ; Smith BF; Agarwal P
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510280
[TBL] [Abstract][Full Text] [Related]
8. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma.
Noguchi S; Mori T; Hoshino Y; Yamada N; Nakagawa T; Sasaki N; Akao Y; Maruo K
J Vet Med Sci; 2012 Jan; 74(1):1-8. PubMed ID: 21836381
[TBL] [Abstract][Full Text] [Related]
10. Prolactin--to be reconsidered in canine mammary tumourigenesis?
Michel E; Rohrer Bley C; Kowalewski MP; Feldmann SK; Reichler IM
Vet Comp Oncol; 2014 Jun; 12(2):93-105. PubMed ID: 22738741
[TBL] [Abstract][Full Text] [Related]
11. Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models.
Lutful Kabir FM; DeInnocentes P; Bird RC
J Cell Biochem; 2015 Dec; 116(12):2956-69. PubMed ID: 26095675
[TBL] [Abstract][Full Text] [Related]
12. Programmed Cell Death Ligand 1 Expression in Canine Cancer.
Shosu K; Sakurai M; Inoue K; Nakagawa T; Sakai H; Morimoto M; Okuda M; Noguchi S; Mizuno T
In Vivo; 2016; 30(3):195-204. PubMed ID: 27107075
[TBL] [Abstract][Full Text] [Related]
13. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated spinal microRNAs induce aggregation of superoxide dismutase 1 protein in canine degenerative myelopathy.
Nakata K; Namiki M; Kobatake Y; Nishida H; Sakai H; Yamato O; Urushitani M; Maeda S; Kamishina H
Res Vet Sci; 2021 Mar; 135():479-485. PubMed ID: 33261827
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as tumour suppressors in canine and human melanoma cells and as a prognostic factor in canine melanomas.
Noguchi S; Mori T; Hoshino Y; Yamada N; Maruo K; Akao Y
Vet Comp Oncol; 2013 Jun; 11(2):113-23. PubMed ID: 23638671
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated microRNA expression in canine uveal melanoma.
Starkey MP; Compston-Garnett L; Malho P; Dunn K; Dubielzig R
Vet Comp Oncol; 2018 Mar; 16(1):81-89. PubMed ID: 28512868
[TBL] [Abstract][Full Text] [Related]
17. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.
Lee HJ; Han HJ; Lee JY; Son WC
Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
Foiani G; Guelfi G; Mandara MT
J Neuropathol Exp Neurol; 2021 Sep; 80(8):769-775. PubMed ID: 34272938
[TBL] [Abstract][Full Text] [Related]
19. Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression.
Lutful Kabir FM; Alvarez CE; Bird RC
Vet Sci; 2015 Dec; 3(1):. PubMed ID: 29056711
[TBL] [Abstract][Full Text] [Related]
20. miR-497 induces apoptosis by the IRAK2/NF-κB axis in the canine mammary tumour.
Zhang T; Feng X; Zhou T; Zhou N; Shi X; Zhu X; Qiu J; Deng G; Qiu C
Vet Comp Oncol; 2021 Mar; 19(1):69-78. PubMed ID: 32706167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
